Abstract

BackgroundThere is mounting evidence for the therapeutic use of faecal microbiota transplant (FMT) in numerous chronic inflammatory diseases. Germ free mice are not always accessible for FMT research and hence alternative approaches using antibiotic depletion prior to FMT in animal studies are often used. Hence, there is a need for standardising gut microbiota depletion and FMT methodologies in animal studies. The aim of this study was to refine gut decontamination protocols prior to FMT engraftment and determine efficiency and stability of FMT engraftment over time.MethodsMale C57BL/6J mice received an antibiotic cocktail consisting of ampicillin, vancomycin, neomycin, and metronidazole in drinking water for 21 days ad libitum. After antibiotic treatment, animals received either FMT or saline by weekly oral gavage for 3 weeks (FMT group or Sham group, respectively), and followed up for a further 5 weeks. At multiple timepoints throughout the model, stool samples were collected and subjected to bacterial culture, qPCR of bacterial DNA, and fluorescent in-situ hybridisation (FISH) to determine bacterial presence and load. Additionally, 16S rRNA sequencing of stool was used to confirm gut decontamination and subsequent FMT engraftment.ResultsAntibiotic treatment for 7 days was most effective in gut decontamination, as evidenced by absence of bacteria observed in culture, and reduced bacterial concentration, as determined by FISH as well as qPCR. Continued antibiotic administration had no further efficacy on gut decontamination from days 7 to 21. Following gut decontamination, 3 weekly doses of FMT was sufficient for the successful engraftment of donor microbiota in animals. The recolonised animal gut microbiota was similar in composition to the donor sample, and significantly different from the Sham controls as assessed by 16S rRNA sequencing. Importantly, this similarity in composition to the donor sample persisted for 5 weeks following the final FMT dose.ConclusionsOur results showed that 7 days of broad-spectrum antibiotics in drinking water followed by 3 weekly doses of FMT provides a simple, reliable, and cost-effective methodology for FMT in animal research.

Highlights

  • The human gut harbours trillions of microbes which include bacteria, archaea, viruses, and eukaryotes

  • In this study we aimed to address these gaps in the literature, by developing a gut decontamination protocol and determining the minimum duration of antibiotic treatment required to efficiently deplete mice of their commensal gut microbiota

  • Stool weight was unchanged for the first 7 days of antibiotic treatment, with subsequent increase in stool weight observed from day 7 to day 17 compared to day 0 (p < 0.001) (Figure S1B)

Read more

Summary

Introduction

The human gut harbours trillions of microbes which include bacteria, archaea, viruses, and eukaryotes. Bacteria and archaea make up most of the gut microbiome, and studies have demonstrated a role for the gut microbiota in influencing disease processes in many organs [1, 2]. Increasing evidence suggests gut manipulation through faecal microbiota transplantation (FMT) has the potential to be beneficial in many diseases [10,11,12]. Animal models are increasingly used to study the effect of gut microbiome manipulation by FMT on disease pathogenesis, and gut based therapeutic interventions. For effective translation of therapeutics targeting the gut microbiota, and to explore the mechanisms underlying hostmicrobe interactions in animals, reconstitution of animals with human donor samples through FMT is key to translational research in this area. The aim of this study was to refine gut decontamination protocols prior to FMT engraftment and determine efficiency and stability of FMT engraftment over time

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call